Page last updated: 2024-08-21

indazoles and Carcinosarcoma

indazoles has been researched along with Carcinosarcoma in 5 studies

Research

Studies (5)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	3 (60.00)	24.3611
2020's	2 (40.00)	2.80

Authors

Authors	Studies
Futamura, M; Hayashi, H; Makiyama, A; Matsuhashi, N; Miyazaki, T; Murase, K; Okumura, N; Saigo, C; Takahashi, T; Takeuchi, T; Tanaka, Y; Yasufuku, I; Yoshida, K	1
Ebata, T; Fujiwara, K; Fujiwara, Y; Hasegawa, K; Kato, T; Nishikawa, T; Noguchi, E; Shimomura, A; Sudo, K; Tamura, K; Yonemori, K	1
Ebi, H; Ikeda, H; Kotani, H; Ohtsubo, K; Takeuchi, S; Tanimoto, A; Yamada, T; Yamashita, K; Yano, S	1
Brady, WE; Campos, SM; DiSilvestro, PA; Hanjani, P; Hensley, ML; Lee, PS; Moxley, KM; O'Cearbhaill, RE; O'Malley, DM; Rose, PG; Rotmensch, J; Thaker, PH; Zuna, RE	1
Fujiwara, K; Hasegawa, K; Kozawa, E; Nishikawa, T; Yabuno, A; Yasuda, M; Yoshida, H	1

Reviews

1 review(s) available for indazoles and Carcinosarcoma

Article	Year
Gastric carcinosarcoma with FGFR2 amplification under long-term control with pazopanib: a case report and literature review. BMC gastroenterology, 2022, Jul-28, Volume: 22, Issue:1 Topics: Aged; Carcinosarcoma; Gastrectomy; Humans; Indazoles; Male; Pyrimidines; Receptor, Fibroblast Growth Factor, Type 2; Stomach Neoplasms; Sulfonamides	2022

Trials

1 trial(s) available for indazoles and Carcinosarcoma

Article	Year
A phase II evaluation of pazopanib in the treatment of recurrent or persistent carcinosarcoma of the uterus: a gynecologic oncology group study. Gynecologic oncology, 2014, Volume: 133, Issue:3 Topics: Aged; Angiogenesis Inhibitors; Carcinosarcoma; Disease-Free Survival; Female; Humans; Indazoles; Middle Aged; Mixed Tumor, Mullerian; Neoplasm Recurrence, Local; Pyrimidines; Receptors, Vascular Endothelial Growth Factor; Sulfonamides; Treatment Outcome; Uterine Neoplasms	2014

Article

Year

A phase II evaluation of pazopanib in the treatment of recurrent or persistent carcinosarcoma of the uterus: a gynecologic oncology group study.

Gynecologic oncology, 2014, Volume: 133, Issue:3

Topics: Aged; Angiogenesis Inhibitors; Carcinosarcoma; Disease-Free Survival; Female; Humans; Indazoles; Middle Aged; Mixed Tumor, Mullerian; Neoplasm Recurrence, Local; Pyrimidines; Receptors, Vascular Endothelial Growth Factor; Sulfonamides; Treatment Outcome; Uterine Neoplasms

2014

Other Studies

3 other study(ies) available for indazoles and Carcinosarcoma

Article	Year
Treatment Outcome of Second-Line Chemotherapy for Gynecologic Carcinosarcoma. Oncology, 2020, Volume: 98, Issue:10 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinosarcoma; Docetaxel; Doxorubicin; Female; Humans; Ifosfamide; Indazoles; Middle Aged; Ovarian Neoplasms; Paclitaxel; Prognosis; Progression-Free Survival; Pyrimidines; Retrospective Studies; Sulfonamides; Treatment Outcome; Uterine Neoplasms	2020
Pulmonary carcinosarcoma showing an obvious response to pazopanib: a case report. BMC pulmonary medicine, 2018, Dec-12, Volume: 18, Issue:1 Topics: Aged; Angiogenesis Inhibitors; Antineoplastic Agents; Brain Neoplasms; Carcinosarcoma; Chemotherapy, Adjuvant; Dose-Response Relationship, Drug; Humans; Indazoles; Lung Neoplasms; Male; Meningeal Neoplasms; Neoplasm Staging; Pneumonectomy; Pyrimidines; Radiosurgery; Sulfonamides; Thrombocytopenia; Treatment Outcome	2018
Pazopanib as a second line treatment for uterine and ovarian carcinosarcoma: a single institutional study. Journal of gynecologic oncology, 2017, Volume: 28, Issue:1 Topics: Aged; Antineoplastic Agents; Carcinosarcoma; Female; Humans; Indazoles; Middle Aged; Ovarian Neoplasms; Pyrimidines; Sulfonamides; Tomography, X-Ray Computed; Uterine Neoplasms	2017